No.1 Healthcare & Pharma Industry Magazine for Middle East & Africa
KENYA —German biopharmaceutical company Boehringer Ingelheim has opened its new scientific office in Nairobi, Kenya, which will serve as the company’s headquarters for the Sub-Saharan Africa region. The move demonstrates…
Read More
GERMANY — Boehringer Ingelheim and 3T Biosciences have formed a strategic partnership and licensing agreement to develop next-generation cancer immunotherapies. Cancer immunotherapy uses the immune system to attack tumor cells…
Read More
EGYPT – Ibnsina Pharma (ISPH) has entered into an exclusive distribution pact with global pharmaceutical company Boehringer Ingelheim. Under the distribution pact, ISPH has agreed to distribute Boehringer Ingelheim’s biopharmaceutical…
Read More
GERMANY – Boehringer Ingelheim has officially entered the dermatological arena having been granted approval by US Food and Drug Administration (FDA) for a drug in a skin disease indication, reports…
Read More
GERMANY – Boehringer Ingelheim, a leading research-driven biopharmaceutical company, the life science company Evotec SE and bioMérieux have formed a joint venture, Aurobac, to create the next generation of antimicrobials…
Read More
GERMANY – Boehringer Ingelheim and the Agency for Science, Technology and Research (A*STAR) have announced a global licensing agreement under which Boehringer Ingelheim will obtain exclusive worldwide rights to develop…
Read More
INDIA – Global pharmaceutical company, Boehringer Ingelheim has received approval from the Central Drugs Standard Control Organization (CDSCO) to market its innovative cardiac drug Jardiance (empagliflozin) in India. Following Jardiance’s…
Read More
GERMANY –Boehringer Ingelheim and biotech startup VantAI have entered into an early discovery research collaboration to identify new protein degraders with enhanced properties against traditionally “undruggable” disease targets, the companies…
Read More
USA – ArrePath, a drug discovery startup, announced a US$20 million seed funding round led by the Boehringer Ingelheim Venture Fund, Insight Partners, and Innospark Ventures. Viva BioInnovator, Arimed Capital,…
Read More
GERMANY – Boehringer Ingelheim, a leading research-driven biopharmaceutical company, and Lifebit Biotech, Ltd, a precision medicine software company, have announced a partnership in which Lifebit will assist Boehringer Ingelheim in…
Read More